Generative AI technologies like ChatGPT could improve patient-oriented clinical practice guidelines in Japan, which are currently underdeveloped. AI could help simplify complex medical information and customise content, potentially benefiting other countries too. However, expert review remains necessary to ensure accuracy.

**For healthcare organizations and medical technology companies:** You can leverage generative AI to enhance your clinical practice guidelines. This could lead to improved patient care and potentially reduced costs. Consider investing in AI-powered tools to simplify complex medical information, making it more accessible to both healthcare providers and patients. **For AI development firms:** There's a significant opportunity to create specialized AI solutions for the healthcare sector, particularly in markets like Japan where patient-oriented guidelines are underdeveloped. You'll need to collaborate closely with medical experts to ensure accuracy and reliability of your AI-generated content.

Expect a surge in AI-assisted medical guideline development across various countries. You'll likely see increased partnerships between AI companies and healthcare institutions to create more patient-friendly, customized medical information. Be prepared for potential regulatory changes as governments grapple with ensuring the accuracy and safety of AI-generated medical guidelines. Watch for emerging best practices in combining AI capabilities with human expertise in the medical field. Consider how your organization can adapt to this trend, whether by developing in-house AI capabilities or partnering with AI providers to stay competitive in an increasingly AI-enhanced healthcare landscape.